Elen Höglander
Impact in
-
- Cancer Diagnosis and Treatment
- Cancer Immunotherapy and Biomarkers
-
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
Papers in
- Oncology 3
- Cancer Diagnosis and Treatment 2
- Cancer Immunotherapy and Biomarkers 1
- CAR-T cell therapy research 1
-
- Cancer Genomics and Diagnostics 2
- Breast Cancer Treatment Studies 1
- Co-authors
- Silje Nord (1 shared paper)Ferrán Losa (1 shared paper)Hans Kristian Moen Vollan (2 shared papers)Peter Van Loo (1 shared paper)Bjørn Naume (1 shared paper)Chantal Pauli (2 shared papers)A. Krämer (2 shared papers)Olav Engebraaten (1 shared paper)
- Journals
- ESMO Open (1 paper)Journal of Clinical Oncology (1 paper)Genome Medicine (1 paper)Journal for ImmunoTherapy of Cancer (1 paper)Annals of Oncology (1 paper)
- Partner nations
- SwitzerlandUnited KingdomSpain
In The Last Decade
Elen Höglander
4 papers receiving 34 citations
Peers
Comparison fields: 5 of 19
- Oncology 16
- Cancer Research 7
- Oral Surgery 3
- Pulmonary and Respiratory Medicine 8
- Pathology and Forensic Medicine 4
Countries citing papers authored by Elen Höglander
This map shows the geographic impact of Elen Höglander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elen Höglander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elen Höglander more than expected).
Fields of papers citing papers by Elen Höglander
This network shows the impact of papers produced by Elen Höglander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elen Höglander. The network helps show where Elen Höglander may publish in the future.
Co-authors
The 25 scholars most cited alongside Elen Höglander, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 18 | |
| 2 | 2023 | 9 | |
| 3 | 2022 | 4 | |
| 4 | 2022 | 3 | |
| 5 | 2025 | 0 | |
| 6 | 2021 | 0 |
About Elen Höglander
Elen Höglander is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Immunology and Infectious Diseases, having authored 6 papers that have together received 34 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (2 papers), Cancer Diagnosis and Treatment (2 papers), Breast Cancer Treatment Studies (1 paper), Renal cell carcinoma treatment (1 paper), Lung Cancer Treatments and Mutations (1 paper), Immunotherapy and Immune Responses (1 paper), Cancer Immunotherapy and Biomarkers (1 paper) and CAR-T cell therapy research (1 paper). The work is most often cited by research in Oncology (16 citations), Cancer Research (7 citations), Oral Surgery (3 citations), Pulmonary and Respiratory Medicine (8 citations) and Pathology and Forensic Medicine (4 citations). Elen Höglander has collaborated with scholars based in Switzerland, United Kingdom and Spain. Frequent co-authors include Silje Nord, Ferrán Losa, Hans Kristian Moen Vollan, Peter Van Loo, Bjørn Naume, Chantal Pauli, A. Krämer, Olav Engebraaten, Ethan S. Sokol and Marit Krohn. Their work appears in journals such as ESMO Open, Journal of Clinical Oncology, Genome Medicine, Journal for ImmunoTherapy of Cancer and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.